Newronika S.p.A.

Medical Devices & EquipmentSeries BMilan, Italynewronika.it

Latest round

Series B

Last raised

Feb 2025

Total raised

$25M

Investors

8

About Newronika S.p.A.

A. operates as a developer of AlphaDBS, an implantable device that stimulates the brain for patients affected by Parkinson's disease. The company also offers WebBioBank, an online platform used by healthcare professionals in diagnosing and analyzing biosignals. The platform also enables patients to connect with WebBioBank.

Who invested in Newronika S.p.A.

8 investors across 3 rounds

See all investors in Newronika S.p.A.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Feb 13, 2025

    Amount

    $14M

    Investors

    Locked

  2. Series A

    Sep 25, 2019

    Amount

    $9.2M

    Investors

    Locked

  3. Series A

    Jun 14, 2016

    Amount

    $1.9M

    Investors

    Locked

Questions about Newronika S.p.A.

Who invested in Newronika S.p.A.?

Newronika S.p.A. has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Newronika S.p.A. raised?

Newronika S.p.A. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Newronika S.p.A. last raise money?

Newronika S.p.A.'s most recent round on record is a Series B, in Feb 2025.

What does Newronika S.p.A. do?

Newronika S.p.A. is a medical devices & equipment company.

Where is Newronika S.p.A. headquartered?

Newronika S.p.A. is headquartered in Milan, Italy.

Which VCs invest in companies like Newronika S.p.A.?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Newronika S.p.A.'s stage. Their profiles are linked below.

Raising like Newronika S.p.A.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.